Ki-1 (CD30)-positive large cell lymphoma presented with leukemia: a case report

K Tamura1, H Tashiro, S Kondoh

  • 1Department of Internal Medicine, Miyazaki Prefectural Hospital.

Fukuoka Igaku Zasshi = Hukuoka Acta Medica
|December 1, 1994
PubMed

Insights

This case report details a rare leukemic phase of Ki-1 positive large cell lymphoma in a 77-year-old woman. The findings highlight the importance of considering this lymphoma in differential diagnoses for unexplained anemia and abnormal lymphoid cells.

Area of Science:

  • Hematology
  • Oncology
  • Immunophenotyping

Background:

  • Anaplastic large cell lymphoma (ALCL) is a distinct type of non-Hodgkin lymphoma.
  • Ki-1 (CD30) positivity is a hallmark of ALCL, typically affecting lymph nodes.
  • Leukemic presentation of ALCL is uncommon.

Observation:

  • A 77-year-old woman presented with fatigue and fever, diagnosed with anemia and abnormal lymphoid cells.
  • Peripheral blood and bone marrow revealed diffuse infiltration by these atypical lymphoid cells.
  • Immunophenotypic analysis identified the cells as T-cell lineage, positive for CD30 (Ki-1), CD3, HLA-DR, and CD25.

Findings:

  • The patient was diagnosed with the leukemic phase of Ki-1 positive large cell lymphoma.
  • Differential diagnoses considered included acute megakaryocytic leukemia, malignant histiocytosis, and other lymphomas.
  • The T-cell lineage was confirmed, distinguishing it from B-cell lymphomas.

Implications:

  • This case underscores the rare but possible leukemic manifestation of Ki-1 positive large cell lymphoma.
  • It emphasizes the need to include this diagnosis in the differential for patients with unexplained bone marrow or peripheral blood abnormalities.
  • Accurate immunophenotypic analysis is crucial for correct diagnosis and management of such rare hematologic malignancies.